ClinicalTrials.gg
CompletedNCT02044445Updated May 28, 2014

Is the IVF Outcome Dependent on the Time Interval Between hCG Administration and Oocyte Retrieval?

An interventional study of Oocyte retrieval will be performed 36 h or 38 h after hCG administration in Subfertility, sponsored by Aristotle University Of Thessaloniki. Completed at 1 site in Greece. Open to female participants aged 20 Years to 43 Years. Per ClinicalTrials.gov, last updated 2014-05-28.

Sponsored by Aristotle University Of Thessaloniki · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
154
Allocation
Randomized
Ages
20 Years to 43 Years
Sex
Female
01

Study summary

During controlled ovarian hyperstimulation (COH), human chorionic gonadotrophin (hCG) is administered to trigger the final follicular maturation before oocyte retrieval, in an attempt to mimic the physiologic effects of LH. The hCG is administered when more than three follicles ≥17mm in mean diameter have developed.

The time interval between hCG administration and oocyte retrieval is of critical importance since the time after luteinizing stimulus is a period of intense processes including the start of luteinization, expansion of cumulus cells and oocyte meiotic maturation.

The commonly practiced hCG administration time of 33 to 36 h in most IVF cycles aims to avoiding spontaneous ovulation before oocyte retrieval. However, several studies have shown that significantly more high quality embryos have been obtained with a prolonged hCG-to-oocyte interval of 38 h. It has been hypothesized that longer interval would be beneficial in improving oocyte quality and achieving optimal maturation.

Currently there are no data on the effect of the time interval between hCG administration and oocyte retrieval on IVF outcome in GnRH antagonist cycles. The aim of this study is to determine whether there is any difference in in vitro fertilization outcome when oocyte retrieval takes place at 36 h or 38 h following hCG administration

02

Conditions studied

  • Subfertility

Browse trials for

Keywords

  • IVF, hCG, oocyte retrieval, time interval
03

In context

Infertility

2,541 studies on the registry are indexed under Infertility; 405 are open to participants now.

This study's enrollment of 154 is above the median of 120 across 1,722 interventional studies indexed under Infertility.

Browse Infertility studies →

Lead sponsor

Aristotle University Of Thessaloniki is the lead sponsor of 281 studies on the registry; 57 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 43 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • women undergoing fresh IVF cycle with recombinant FSH and GnRH antagonists
  • regular spontaneous menstrual cycle (24-35 days)
  • age ≤ 43 years
  • FSH ≤ 20 IU/L

Exclusion criteria

Exclusion Criteria:

  • History of previous ovarian surgery
  • Women with Stage III-IV Endometriosis
  • Women undergoing natural cycle IVF
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
154 participants (actual)

Study arms

  • Active comparator
    36 h group

    Oocyte retrieval will be performed 36 hours after hCG administration

    Procedure: Oocyte retrieval will be performed 36 h or 38 h after hCG administration

  • Active comparator
    38 h group

    Oocyte retrieval will be performed 38 hours after hCG administration

    Procedure: Oocyte retrieval will be performed 36 h or 38 h after hCG administration

Interventions

  • ProcedureOocyte retrieval will be performed 36 h or 38 h after hCG administration

    Oocyte retrieval will be performed 36 h or 38 h after hCG administration

    Also known as: oocyte retrieval at 36 hours following hCG administration, oocyte retrieval at 38 hours following hCG administration

06

What researchers measure

Primary outcomes

  1. retrieval rate (cumulus-oocyte complexes/ follicles> 11 mm)

    Time frame: up to 38 h after hCG administration

Secondary outcomes

  1. Clinical pregnancy rate (evidence of intrauterine sac with fetal heart activity at 6-8 weeks of gestation)

    Time frame: At 6-8 weeks of gestation

  2. Total number of oocytes retrieved

    Time frame: up to 38 h after hCG administration

07

Study locations

1 site
  • Unit for Human Reproduction, 1st Dept of Obstetrics and Gynaecology, Medical School, Aristotle University of Thessaloniki
    Thessaloniki, Greece
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 28, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02044445
Responsible party
E.M. Kolibianakis (Assistant Professor, Aristotle University Of Thessaloniki) — Principal investigator
First posted
Jan 24, 2014
Start date
Nov 2009
Primary completion
Dec 2013
Last update
May 28, 2014
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion